Pharmacom ApS: Financial statements 2023
CVR: 40251480
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
Pharmacom ApS (CVR 40251480) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 836,732 and a net result of DKK 8,350 compared with DKK 10,552 the year before. That is an increase of 7.4% compared with the year before. Equity in the 2023 report amounted to DKK 90,455. The solvency ratio was 25.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 836,732
- Profit/Loss
- DKK 8,350
- Equity
- DKK 90,455
- Total Assets
- DKK 359,009
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 837K | 8K | 90K | 1 |
| 2022 | - | 779K | 11K | 82K | 1 |
| 2021 | - | 2.5M | 1.3M | 1.3M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Pharmacom ApS
Pharmacom ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2019. The company has been dissolved on 19 November 2024. The company was registered under the industry Agenturhandel med blandet sortiment. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK 836,732 and a net result of DKK 8,350 compared with DKK 10,552 the year before. Equity in the 2023 report amounted to DKK 90,455.